53
Participants
Start Date
November 30, 2002
Primary Completion Date
October 31, 2006
Study Completion Date
May 31, 2007
calcitriol
dexamethasone
gefitinib
Roswell Park Cancer Institute, Buffalo
Roswell Park Cancer Institute
OTHER